Healthy volunteers test new drug NAV-240 for safety
NCT ID NCT06933043
First seen Jan 05, 2026 · Last updated May 22, 2026 · Updated 22 times
Summary
This early-stage study tested the safety of multiple doses of an experimental drug called NAV-240 in 24 healthy adults aged 18 to 65. Participants received either NAV-240 or a placebo to see what medical problems, if any, occurred. The goal was to gather initial safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network
Brisbane, Queensland, 4006, Australia
Conditions
Explore the condition pages connected to this study.